SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001367982-08-000146
Filing Date
2008-05-30
Accepted
2008-05-30 19:11:44
Documents
1
Period of Report
2008-05-30

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT edgardoc.html 4  
1 PRIMARY DOCUMENT edgardoc.xml 4 3683
  Complete submission text file 0001367982-08-000146.txt   5541
Mailing Address 9360 TOWNE CENTRE DR SUITE 110 SAN DIEGO CA 92121
Business Address 9360 TOWNE CENTRE DR SUITE 110 SAN DIEGO CA 92121 6195522200
AMYLIN PHARMACEUTICALS INC (Issuer) CIK: 0000881464 (see all company filings)

IRS No.: 330266089 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address AMYLIN PHARMACEUTICALS, INC. 885 ARAPAHOE AVENUE BOULDER CO 80302
Business Address 8586427002
GRAHAM GINGER L (Reporting) CIK: 0001192601 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-19700 | Film No.: 08872094